Abstract
AbstractDuring the genomic characterisation of Enterococcus faecium strains (n = 39) collected in a haematology ward, we identified an isolate (OI25), which contained vanA-type vancomycin resistance genes but was phenotypically susceptible to vancomycin. OI25 could revert to resistance when cultured in the presence of vancomycin and was thus considered to be vancomycin-variable. Long-read sequencing was used to identify structural variations within the vancomycin resistance region of OI25 and to uncover its resistance reversion mechanism. We found that OI25 has a reduced ability to positively regulate expression of the vanHAX genes in the presence of vancomycin, which was associated with the insertion of an IS6-family element within the promoter region and the first 50 bp of the vanR gene. The vancomycin-resistant revertant isolates constitutively expressed vanHAX genes at levels up to 36,000-fold greater than OI25 via co-transcription with a ribosomal RNA operon. The vancomycin-resistant revertants did not exhibit a significant growth defect. During VRE outbreaks, attention should be paid to contemporaneous vancomycin-susceptible strains as these may carry silent vancomycin resistance genes that can be activated through genomic rearrangements.
Funder
RCUK | Medical Research Council
Royal Society
Wellcome Trust
Publisher
Springer Science and Business Media LLC
Reference47 articles.
1. Lebreton, F. et al. Emergence of epidemic multidrug-resistant Enterococcus faecium from animal and commensal strains. mBio. 4, e00534–13 (2013).
2. Agudelo Higuita, N. I. & Huycke, M. M. Enterococcal disease, epidemiology, and implications for treatment. In Enterococci: From Commensals to Leading Causes of Drug Resistant Infection 2nd edn, Vol. 3 (eds. Gilmore, M. S., Clewell, D. B., Ike, Y. & Shankar, N.) Ch. 146–166 (Massachusetts Eye and Ear Infirmary, 2014).
3. Miller, W. R., Munita, J. M. & Arias, C. A. Mechanisms of antibiotic resistance in enterococci. Expert. Rev. Anti. Infect. Ther. 12, 1221–1236 (2014).
4. Watanakunakorn, C. Mode of action and in-vitro activity of vancomycin. J. Antimicrob. Chemother. 14, 7–18 (1984).
5. Stogios, P. J. & Savchenko, A. Molecular mechanisms of vancomycin resistance. Protein Sci. 29, 654–669 (2020).